Evidence map›Paper›PMID 40061210›Full record

ArticleMaterials today. Bio2025

Lymphoma-on-chip model reveals that lymph node stromal cells promote diffuse large B-cell lymphoma survival and migration.

Mohammad Jouybar, Aleksandra M Mikula, Nanouk Zuidmeer, Tanja Konijn, A Vera de Jonge, Henk P Roest, Tuna Mutis, Luc J W van der Laan, Reina E Mebius, Jaap M J den Toonder and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. 3DACS biomaterials science & engineering · 2026
    Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mohammad JouybarMicrosystems, Eindhoven University of Technology, Eindhoven, the Netherlands.
Aleksandra M MikulaDepartment of Molecular Cell Biology, Amsterdam UMC Location VU, Amsterdam, the Netherlands.
Nanouk ZuidmeerDepartment of Molecular Cell Biology, Amsterdam UMC Location VU, Amsterdam, the Netherlands.
Tanja KonijnDepartment of Molecular Cell Biology, Amsterdam UMC Location VU, Amsterdam, the Netherlands.
A Vera de JongeCancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands.
Henk P RoestErasmus MC Transplant Institute, University Medical Center Rotterdam, Department of Surgery, Rotterdam, the Netherlands.
Tuna MutisCancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands.
Luc J W van der LaanErasmus MC Transplant Institute, University Medical Center Rotterdam, Department of Surgery, Rotterdam, the Netherlands.
Reina E MebiusDepartment of Molecular Cell Biology, Amsterdam UMC Location VU, Amsterdam, the Netherlands.
Jaap M J den ToonderMicrosystems, Eindhoven University of Technology, Eindhoven, the Netherlands.
Charlotte M de WindeDepartment of Molecular Cell Biology, Amsterdam UMC Location VU, Amsterdam, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive B-cell non-Hodgkin lymphoma, often developing resistance to current treatments. Development and testing of new therapies is hampered by lack of good

Indexed as

Diffuse large B-Cell lymphomaLymphatic vesselLymph nodeLymph node stromal cellsLymphoma-on-ChipTumor microenvironmentVessel-on-Chip

Identifiers

PMID40061210
PMCPMC11889632

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.